drugset / Trial / NCT00093678

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

NCT00093678 ↗

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Celecoxib may help relieve moderate or severe pain associated with cancer. It may also decrease weight loss and improve muscle strength in cancer patients. PURPOSE: This randomized clinical trial is studying celecoxib to see how well it works in managing pain, weight loss, and weakness in patients with advanced cancer.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — Oral